English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Novartis
Amanda Rupp
| Aug 31, 2016
Sandoz's Erelzi gains FDA approval for multiple inflammatory diseases
Jamie Barrand
| Feb 20, 2016
Novartis' new AML therapy granted FDA Breakthrough Designation
Jamie Barrand
| Feb 20, 2016
Alcon, Transcend Medical partner on glaucoma therapy project
Jamie Barrand
| Feb 13, 2016
Sandoz acquires infliximab inhibitor treatment from Pfizer
Kasey Schefflin- Emrich
| Jan 28, 2016
FDA approves Cosentyx as treatment for two inflammatory conditions
Trending
+
Regulatory
C.D. Marsden
| Apr 12, 2025
Empower Pharmacy: Eli Lilly lawsuit is ‘Big Pharma’s attempt to limit patient and provider choice’
+
Community
Patient Daily
| Apr 17, 2025
ENT Practice Expert: OTO Forum 2025 will feature 'at least four topics that stand out as vital for doctors'
+
Pharmaceuticals
Patient Daily
| Apr 15, 2025
UCSF neurosurgeon: '340B is a drug discount program that hospitals exploit as an additional revenue stream'
+
Pharmaceuticals
Patient Daily
| Apr 15, 2025
President of Drug Channels Institute: 'Hospital prices are significantly higher at large 340B hospitals'
« First
«
1
2
3
